Similar Items: Profiles and Disease Burden of Patients with COPD Initiating Triple Therapy in China
- The Disproportionate Burden of Cardiovascular Disease in Mild-to-Moderate COPD
- Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]
- From China’s Multicenter Prospective Cohort: Right Ventricular Afterload and Prognosis in Hospitalized Patients with Acute Exacerbation of COPD
- Development and Interpretable Machine Learning-Based Prediction of Cardiovascular Disease Risk in Chinese COPD Patients: An Analysis of the CHARLS Database
- Sociodemographic Determinants of Hospitalized Exacerbations in Exposure-Defined COPD Phenotypes: A Nationwide Prospective Cohort Study in China
- Development and Validation of an Explainable Machine Learning Model for Identification of Dysphagia in Patients with COPD